SCARNA1

Across TCGA pan-cancer cohorts, SCARNA1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SCARNA1’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where SCARNA1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SCARNA1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

UCEC, CHOL, and THCA are the cancer types where SCARNA1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SCARNA1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	II,III,IV	+0.552	.004	4	view →
CHOL	All	All	+0.298	.009	1	view →
THCA	All	All	−0.118	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

SCARNA1–UCEC

Open the UCEC breakdown →